MedPath

Study of risk reducing contralateral mastectomy (RRM) for Japanese BRCA1/2 mutation carriers

Not Applicable
Conditions
hereditary breast and ovarian cancer
Registration Number
JPRN-UMIN000031603
Lead Sponsor
Juntendo University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1.Intrelance to RRM for other disease 2.Women with breast cancer of contralateral breast

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence and mortality rate of the breast cancer on BRCA1/2 mutation carrier performed risk reduction contralateral mastectomy
Secondary Outcome Measures
NameTimeMethod
Adverse event related to RRM
© Copyright 2025. All Rights Reserved by MedPath